IBDEI0DG ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17975,1,5,0)
 ;;=5^Family H/O Anemia
 ;;^UTILITY(U,$J,358.3,17975,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,17976,0)
 ;;=V17.5^^110^993^7
 ;;^UTILITY(U,$J,358.3,17976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17976,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,17976,1,5,0)
 ;;=5^Family H/O Asthma
 ;;^UTILITY(U,$J,358.3,17976,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,17977,0)
 ;;=V17.7^^110^993^6
 ;;^UTILITY(U,$J,358.3,17977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17977,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,17977,1,5,0)
 ;;=5^Family H/O Arthritis
 ;;^UTILITY(U,$J,358.3,17977,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,17978,0)
 ;;=V19.0^^110^993^8
 ;;^UTILITY(U,$J,358.3,17978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17978,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,17978,1,5,0)
 ;;=5^Family H/O Blindness
 ;;^UTILITY(U,$J,358.3,17978,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,17979,0)
 ;;=V16.3^^110^993^9
 ;;^UTILITY(U,$J,358.3,17979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17979,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,17979,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,17979,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,17980,0)
 ;;=V16.41^^110^993^12
 ;;^UTILITY(U,$J,358.3,17980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17980,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,17980,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,17980,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,17981,0)
 ;;=V16.42^^110^993^13
 ;;^UTILITY(U,$J,358.3,17981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17981,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,17981,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,17981,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,17982,0)
 ;;=V16.43^^110^993^14
 ;;^UTILITY(U,$J,358.3,17982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17982,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,17982,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,17982,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,17983,0)
 ;;=V19.5^^110^993^15
 ;;^UTILITY(U,$J,358.3,17983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17983,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,17983,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,17983,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,17984,0)
 ;;=V19.2^^110^993^16
 ;;^UTILITY(U,$J,358.3,17984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17984,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,17984,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,17984,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,17985,0)
 ;;=V17.3^^110^993^18
 ;;^UTILITY(U,$J,358.3,17985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17985,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,17985,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,17985,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,17986,0)
 ;;=V16.6^^110^993^19
 ;;^UTILITY(U,$J,358.3,17986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17986,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,17986,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,17986,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,17987,0)
 ;;=V18.61^^110^993^21
 ;;^UTILITY(U,$J,358.3,17987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17987,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,17987,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,17987,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,17988,0)
 ;;=V17.0^^110^993^22
 ;;^UTILITY(U,$J,358.3,17988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17988,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,17988,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,17988,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,17989,0)
 ;;=V19.4^^110^993^23
 ;;^UTILITY(U,$J,358.3,17989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17989,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,17989,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,17989,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,17990,0)
 ;;=V17.1^^110^993^24
 ;;^UTILITY(U,$J,358.3,17990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17990,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,17990,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,17990,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,17991,0)
 ;;=V16.8^^110^993^20
 ;;^UTILITY(U,$J,358.3,17991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17991,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,17991,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,17991,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,17992,0)
 ;;=V11.1^^110^993^47
 ;;^UTILITY(U,$J,358.3,17992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17992,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,17992,1,5,0)
 ;;=5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,17992,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,17993,0)
 ;;=V15.89^^110^993^55
 ;;^UTILITY(U,$J,358.3,17993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17993,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,17993,1,5,0)
 ;;=5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,17993,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,17994,0)
 ;;=V11.3^^110^993^48
 ;;^UTILITY(U,$J,358.3,17994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17994,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,17994,1,5,0)
 ;;=5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,17994,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,17995,0)
 ;;=V15.07^^110^993^49
 ;;^UTILITY(U,$J,358.3,17995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17995,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,17995,1,5,0)
 ;;=5^Personal H/O Allergy to Latex
 ;;^UTILITY(U,$J,358.3,17995,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,17996,0)
 ;;=V13.4^^110^993^50
 ;;^UTILITY(U,$J,358.3,17996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17996,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,17996,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,17996,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,17997,0)
 ;;=V12.72^^110^993^51
 ;;^UTILITY(U,$J,358.3,17997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17997,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,17997,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,17997,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,17998,0)
 ;;=V12.59^^110^993^52
 ;;^UTILITY(U,$J,358.3,17998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17998,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,17998,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,17998,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,17999,0)
 ;;=V45.81^^110^993^53
 ;;^UTILITY(U,$J,358.3,17999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17999,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,17999,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,17999,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,18000,0)
 ;;=V15.84^^110^993^54
 ;;^UTILITY(U,$J,358.3,18000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18000,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,18000,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,18000,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,18001,0)
 ;;=V15.85^^110^993^60
 ;;^UTILITY(U,$J,358.3,18001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18001,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,18001,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,18001,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,18002,0)
 ;;=V10.72^^110^993^56
 ;;^UTILITY(U,$J,358.3,18002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18002,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,18002,1,5,0)
 ;;=5^Personal H/O Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,18002,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,18003,0)
 ;;=V15.3^^110^993^57
 ;;^UTILITY(U,$J,358.3,18003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18003,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,18003,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,18003,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,18004,0)
 ;;=V10.61^^110^993^32
 ;;^UTILITY(U,$J,358.3,18004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18004,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,18004,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,18004,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,18005,0)
 ;;=V12.03^^110^993^33
 ;;^UTILITY(U,$J,358.3,18005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18005,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,18005,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,18005,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,18006,0)
 ;;=V10.82^^110^993^34
 ;;^UTILITY(U,$J,358.3,18006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18006,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,18006,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,18006,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,18007,0)
 ;;=V10.62^^110^993^36
 ;;^UTILITY(U,$J,358.3,18007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18007,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,18007,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,18007,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,18008,0)
 ;;=V10.63^^110^993^35
 ;;^UTILITY(U,$J,358.3,18008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18008,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,18008,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,18008,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,18009,0)
 ;;=V11.2^^110^993^30
 ;;^UTILITY(U,$J,358.3,18009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18009,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,18009,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,18009,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,18010,0)
 ;;=V15.81^^110^993^46
 ;;^UTILITY(U,$J,358.3,18010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18010,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,18010,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,18010,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,18011,0)
 ;;=V10.43^^110^993^37
 ;;^UTILITY(U,$J,358.3,18011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18011,1,4,0)
 ;;=4^V10.43
